DSpace Repository

Effect of 20-hydroxyecdysone on proteolytic regulation in skeletal muscle atrophy

Show simple item record

dc.contributor.author Hirunsai M.
dc.contributor.author Yimlamai T.
dc.contributor.author Suksamrarn A.
dc.date.accessioned 2021-04-05T03:23:23Z
dc.date.available 2021-04-05T03:23:23Z
dc.date.issued 2016
dc.identifier.issn 0258851X
dc.identifier.other 2-s2.0-84994246675
dc.identifier.uri https://ir.swu.ac.th/jspui/handle/123456789/13345
dc.identifier.uri https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994246675&doi=10.21873%2finvivo.11007&partnerID=40&md5=6a1b5fcb0dcc58301598696d69588ae3
dc.description.abstract Background/Aim: 20-Hydroxyecdystone (20E) is an ecdysteroid hormone which controls molting and reproduction in arthropods. 20E also produces a variety of effects in vertebrates, including enhancing protein synthesis and skeletal muscle regeneration. The effect of 20E on disuse muscle atrophy has not been reported to date. This study examined the proteolytic regulation of 20E in tenotomized rat slow soleus and fast plantaris muscles. Materials and Methods: Male Wistar rats were randomly divided into three groups: sedentary control (CON), tenotomy without 20E treatment (TEN), and tenotomy with treatment of 5 mg/kg BW of 20E (TEN+20E). The TEN+20E group was administered 20E via subcutaneous injection to the right thigh for 7 days after tenotomy. Results: 20E treatment tended to attenuate disuse muscle atrophy and reduced ubiquitination only in soleus muscle. Conclusion: 20E treatment alleviates skeletal muscle atrophy partially mediated by ubiquitinate pathway, dependent on the muscle phenotype. © 2016, International Institute of Anticancer Research. All rights reserved.
dc.subject ecdysterone
dc.subject muscle protein
dc.subject muscle RING finger 1 protein
dc.subject ecdysterone
dc.subject ubiquitinated protein
dc.subject achilles tendon
dc.subject adult
dc.subject animal experiment
dc.subject animal model
dc.subject animal tissue
dc.subject Article
dc.subject body weight
dc.subject controlled study
dc.subject histology
dc.subject male
dc.subject muscle atrophy
dc.subject muscle mass
dc.subject muscle wet weight
dc.subject nonhuman
dc.subject plantaris muscle
dc.subject protein degradation
dc.subject protein expression
dc.subject rat
dc.subject skeletal muscle
dc.subject soleus muscle
dc.subject tenotomy
dc.subject ubiquitination
dc.subject Western blotting
dc.subject animal
dc.subject drug effects
dc.subject metabolism
dc.subject muscle atrophy
dc.subject pathology
dc.subject protein degradation
dc.subject randomization
dc.subject signal transduction
dc.subject skeletal muscle
dc.subject subcutaneous drug administration
dc.subject Wistar rat
dc.subject Animals
dc.subject Blotting, Western
dc.subject Ecdysterone
dc.subject Injections, Subcutaneous
dc.subject Male
dc.subject Muscle, Skeletal
dc.subject Muscular Atrophy
dc.subject Proteolysis
dc.subject Random Allocation
dc.subject Rats, Wistar
dc.subject Signal Transduction
dc.subject Tenotomy
dc.subject Ubiquitinated Proteins
dc.subject Ubiquitination
dc.title Effect of 20-hydroxyecdysone on proteolytic regulation in skeletal muscle atrophy
dc.type Article
dc.rights.holder Scopus
dc.identifier.bibliograpycitation In Vivo. Vol 30, No.6 (2016), p.869-877
dc.identifier.doi 10.21873/invivo.11007


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics